This site is intended for US patients and caregivers.

FENNEC HEARS logo

Welcome to Fennec HEARS™

Welcome to Fennec HEARS™

Your source for access support

At Fennec HEARS™, our priority is making sure you have the support your family needs now. Fennec HEARS™ is a single source program for both patient financial and product access support.

Affording PEDMARK

At Fennec, we don’t want cost to stand in the way of your child getting PEDMARK.

  • If you have commercial or private health insurance: Fennec HEARS™ may be able to offer you copay assistance in the form of a $0 copay card

How to enroll:

  • If you have Medicaid (government insurance): Copay assistance may be available through independent charities. Contact a Fennec HEARS™ Care Coordinator for a list of potential resources

    NOTE: Independent copay assistance foundations have their own rules for eligibility. We can only refer you to a foundation that supports your child’s disease state. We cannot guarantee a foundation will help you.
  • If you are uninsured: The Fennec Patient Assistance Program is committed to providing access to PEDMARK for eligible patients without insurance coverage. To see if you qualify for assistance, call a Fennec HEARS™ Care Coordinator

Our Care Coordinators get you started

Once your doctor has prescribed PEDMARK, you can call a Fennec HEARS™ Care Coordinator to help:

  • Answer insurance questions about coverage for PEDMARK
  • Provide you with tips and resources for managing your child’s treatment

A Fennec HEARS™ professional does not offer medical advice or replace discussions with a healthcare provider.

Contact a Fennec HEARS™ Care Coordinator at 1-833-7PEDMARK (1-833-773-3627)

from 9 am to 6 pm ET, Monday through Friday.

IMPORTANT SAFETY INFORMATION

  • Do not allow your child to receive PEDMARK if they have had a severe allergic reaction to sodium thiosulfate or any of the other ingredients in PEDMARK.
  • Allergic reactions can happen with PEDMARK and can be serious and life-threatening. Your healthcare provider will monitor your child for allergic reactions during the PEDMARK infusion. Your healthcare provider will stop the infusion and provide treatment if your child has an allergic reaction. If your child has an allergic reaction, your healthcare provider will give your child certain medicines before each PEDMARK infusion. Tell your healthcare provider right away if your child has any of these signs of an allergic reaction: rash, hives (raised bumps), chest tightness, wheezing, trouble breathing, swelling of the face, lips, tongue, or throat.
  • Changes in salt and potassium levels in the blood are common with PEDMARK but can also be serious. Your healthcare provider will do blood tests to check your child’s sodium and potassium levels before starting and as needed during treatment with PEDMARK. Tell your healthcare provider right away if your child develops any of the following signs or symptoms: feeling tired or weak, feeling restless, muscle weakness, seizures.
  • Nausea and vomiting are common with PEDMARK but can also be serious. Your healthcare provider will give your child medicines before each PEDMARK infusion to help prevent nausea and vomiting.
  • The most common side effects of PEDMARK include decreased red blood cells (anemia).
  • These are not all the possible side effects of PEDMARK. Call your child’s doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.  You may also report side effects to Fennec Pharmaceuticals, Inc. at 1-833-336-6321.

Please see full Prescribing Information, including Patient Information, for PEDMARK.

WHAT IS PEDMARK?

PEDMARK is a prescription medicine used to decrease the risk of hearing loss in children 1 month of age and older who are receiving cisplatin for solid tumors (cancer) that have not spread to other parts of the body.

It is not known if PEDMARK is safe and effective when given after cisplatin infusions longer than 6 hours.

It is not known if PEDMARK is safe and effective in children less than 1 month of age. PEDMARK is not recommended in children younger than 1 month of age.